Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check6 days agoChange DetectedFooter and site-wide navigation/policy elements were removed from the page, reducing the amount of footer information visible on the study record.SummaryDifference22%

- Check14 days agoChange DetectedRecruitment status now indicates no active enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the treatment heading formatting was adjusted (Intervention/Treatment).SummaryDifference0.5%

- Check21 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5. This reflects a minor update to the page or site template.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, reflecting a new metadata version for the page. No content or functionality changes are introduced.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than any change to the study record content.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.